Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells

BACKGROUND: Norcantharidin (NCTD) is a Chinese FDA approved, chemically synthesized drug for cancer treatment. The effect of NCTD on signaling proteins of EGFR and c-Met was systematically elucidated in current study. METHODS: Two human colon cancer cell lines, HCT116 and HT29, were used as model sy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Qiu, Peiju, Wang, Siwen, Liu, Ming, Ma, He, Zeng, Xuan, Zhang, Meng, Xu, Lingling, Cui, Yidi, Xu, Huixin, Tang, Yang, He, Yanli, Zhang, Lijuan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237309/
https://ncbi.nlm.nih.gov/pubmed/28086832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-3039-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi